Copy For Citation
Soydal Ç., Araz M., Ürün Y., Nak D., Özkan E., Küçük N. Ö.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.65, no.3, pp.282-286, 2021 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
65
Issue:
3
-
Publication Date:
2021
-
Doi Number:
10.23736/s1824-4785.19.03165-0
-
Journal Name:
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
-
Page Numbers:
pp.282-286
-
Keywords:
Prostatic neoplasms, Prostate-specific antigen, Survival, RADIOLIGAND THERAPY, RADIATION-DOSIMETRY, PSMA
-
Ankara University Affiliated:
Yes
Abstract
BACKGROUND: This study aims to analyze the prognostic importance of serum prostate specific antigen (PSA) response in patients who received radioligand therapy (RLT) with Lu-177 Prostate-specific membrane antigen (PSMA) for their castration-resistant prostate cancer.